Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
The
Un
iver
sity
of
No
ttin
gh
am
Standardisation and Security of Nuclear Medicine Services
Alan Perkins
University of Nottingham
The analysts’ dilemma. RSC 30 June 2011
The
Un
iver
sity
of
No
ttin
gh
am Standard chamber Setting standards Basic Safety Standards
The
Un
iver
sity
of
No
ttin
gh
am
Warning!
This presentation may require revision to meet the required standards.
The
Un
iver
sity
of
No
ttin
gh
am
Standardisation Dictionary definitions: •cause (something) to conform to a standard. •determine the properties of (something) by comparison with a standard. •the process of establishing a standard which could be a technical standard, standard test method, standard definition, standard procedure (or practice)….
The
Un
iver
sity
of
No
ttin
gh
am
The National Institute for Health and Clinical Excellence (NICE) provides guidance, sets quality standards and manages a national database to improve people's health and prevent and treat ill health. Technology appraisals Recommendations on the use of new and existing medicines and treatments within the NHS, such as: •Medicines •medical devices (for example, hearing aids or inhalers) •diagnostic techniques (tests used to identify diseases) •surgical procedures (such as repairing hernias) •health promotion activities (for example, ways of helping people with diabetes manage their condition).
The
Un
iver
sity
of
No
ttin
gh
am
Standards in Nuclear Medicine
The
Un
iver
sity
of
No
ttin
gh
am
References
1. International basic safety standards for protection against ionizing radiation and for the safety of radiation sources. Safety series 117 IAEA Vienna 1996.
2. Applying radiation safety standards in nuclear medicine. Safety reports series 40 IAEA Vienna 2005.
3. Nuclear Medicine Resources Manual. IAEA Vienna 2006. 4. ICRP Publication 94: Release of Patients after Therapy with Unsealed
Radionuclides. International Commission on Radiological Protection ISBN 0080445608 2005
5. Medical and dental guidance notes. IPEM York 2002
The
Un
iver
sity
of
No
ttin
gh
am
Global Perspective of Safety Standards
• Different perception of value of nuclear medicine
• Difference in priorities between different countries
• Complex relationships between practitioners,
researchers, industry and regulatory authorities
• Variable safety standards
• Implementation through peer review and audit
• Vast discrepancy in resources between different
countries
The
Un
iver
sity
of
No
ttin
gh
am Service Guidelines
Guidelines in Nuclear Medicine have been, and continue to be, developed by a number of organisations throughout the world. National regulations on the administration of radioactive substances and differences in clinical service delivery mean that guidelines do not readily apply across regional and national boundaries. In Europe, the European Association of Nuclear Medicine (EANM) is coordinating the development of guidelines, but recognises the need for national guidelines.
The
Un
iver
sity
of
No
ttin
gh
am
The
Un
iver
sity
of
No
ttin
gh
am
The
Un
iver
sity
of
No
ttin
gh
am
Audit and Standards Quality of Service Health and Safety
Standards relate to Legal requirements Regulatory obligations Notes for guidance Peer reviewed publications Accepted good clinical practice (GCP)
The
Un
iver
sity
of
No
ttin
gh
am
Example Radiopharmaceuticals for GI transit
Beef stew 99mTc Chicken liver 99mTc Dietry fibre 111In, 131I Egg sandwich 99mTc Filter paper in corn flakes (Technicrispies) 99mTc Mushrooms 99mTc Oatmeal 99mTc Pancake 99mTc,111In Porridge 99mTc,51Cr Rice 99mTc Scrambled egg on toast 99mTc
The
Un
iver
sity
of
No
ttin
gh
am
SNM guideline Wide range of test meals used yet rarely validated 118ml (4oz) liquid egg whites 18 – 37MBq Tc-99m Su colloid Cook eggs in microwave oven to consistency of an omelette. 2 slices of toasted white bread 30g jam or jelly 120ml water May be eaten as a sandwich!
The
Un
iver
sity
of
No
ttin
gh
am
The
Un
iver
sity
of
No
ttin
gh
am
Security
• Safety.
• Continuation of service through secure supplies.
The
Un
iver
sity
of
No
ttin
gh
am
Post 9/11….. In the UK the police and Environment Agency Inspectors have been visiting departments to assess security. Previously dealing with accidental spill or loss but now…….
The
Un
iver
sity
of
No
ttin
gh
am
WARNING ! RADIO INACTIVE
New Scientist 13 September 2008 British Medical Journal 2008;337:a1577
The
Un
iver
sity
of
No
ttin
gh
am
Medical Molybdenum Production
Reactor Tc-99m
Generator Manufacturing
Uranium-235 Mo-99 Tc-99m
Nuclear Pharmacy
Tc-99m and Companion Drug
Bulk Mo-99 Processing
Patient
Decay of Isotopes (“Half Life”)
• Mo-99: 66 hours
• Tc-99m: 6 hours
About 3-4 days
The
Un
iver
sity
of
No
ttin
gh
am
Molybdenum Deficiency
• Molybdenum deficiency is very rare recessive disorder that occurs when the body is lacking or cannot break down molybdenum.
• Like many other minerals, molybdenum is necessary for the the metabolisation of fats, carbohydrates, copper and nitrogen.
• It is normally obtained through a diet of beans, dark green leafy vegetables, rice and cereals.
• Those with the greatest risk of developing it are patients being fed intravenously.
The
Un
iver
sity
of
No
ttin
gh
am
5 reactors produce over 90% world supply
The
Un
iver
sity
of
No
ttin
gh
am
Aging Fleet of Major Production Reactors
Location Name Age
Canada, Chalk River NRU 51
Belgium, Mol BR2 47
Netherlands, Petten HFR 47
South Africa, Pelindaba SAFARI-1 43
France, Saclay OSIRIS 42
The
Un
iver
sity
of
No
ttin
gh
am
Medical Isotopes – Global Supply Chain Structure
OSIRIS
MDS Nordion AECL
Lantheus (BMS)
Covidien
Covidien US
IRE IBA
NTP NTP
NRU
PETTEN
BR-2
Target Irradiation
Mo-99 Extraction
Mo-99 Purification
Tc-99m Generator Manufacturing &
Distribution
SAFARI AEC Amersham
Nuclear Medicine Market
Canada & US
Canada, US & Europe
Europe
Europe and ROW
Canada
Netherlands
Belgium
France
South Africa
Reactors Facilities
Covidien EU
Nihon
Daichi Japan
Czech LWR-15 REZ
MARIA Poland
Czech
Poland
The
Un
iver
sity
of
No
ttin
gh
am
National Society Role
Communication Establish accurate communication with departments Ensure flow of information for service planning Society website www.bnms.org RSS feed
Engage with clinical departments Working groups Establish best practice Share solutions to short term shortages Include relevant information in surveys Education of users
The
Un
iver
sity
of
No
ttin
gh
am
Securing the supply Increased co-operation
Producers
Manufacturers
International Agencies e.g. OECD
Professional Societies
Hospital radiopharmacies
Service departments
The
Un
iver
sity
of
No
ttin
gh
am
Industry: AIPES established 1987
CYCLOPHARMALABORATOIRES
The
Un
iver
sity
of
No
ttin
gh
am
National and International Collaboration
• COMMUNICATE WITH ALL STAKEHOLDERS IN CASE OF SHORTAGE
• EVALUATE AVAILABLE PRODUCTION AND IDENTIFY ALTERNATIVE SOURCES
• PROPOSE ALTERNATIVE ISOTOPES and DIAGNOSTIC PROCEDURES WHEN AVAILABLE
• PROVIDE ACCESS TO INFORMATION AND EXPERTISE TO THE MEDIA
• WORK WITH INDUSTRY AND AUTHORITIES FOR A LONG TERM SOLUTION
27
The
Un
iver
sity
of
No
ttin
gh
am
OCTOBER 2010
F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M T
u W Th F Sa Su
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Week 40 Week 41 Week 42 Week 43 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez
NOVEMBER 2010
M Tu W Th F Sa Su M Tu W Th F Sa Su M T
u W Th F Sa Su M Tu W Th F Sa Su M Tu
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 -
Week 44 Week 45 Week 46 Week 47 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez
December 2010
W Th F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M T
u W Th F Sa Su M Tu W Th F
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Week 48 Week 49 Week 50 Week 51 Week 52 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez
The
Un
iver
sity
of
No
ttin
gh
am
Key Challenges • Isotope Production
– Limited number of aging reactors – Limited new sources of supply – New sources require significant time and investment to
deploy • Supply Chain
– Logistics of delivery of a decaying product – Complex supply chain with multiple public and private
sector participants • Regulation
– Radioactivity + Pharmacueticals (GMP) – Nuclear security – HEU/LEU – Transport
The
Un
iver
sity
of
No
ttin
gh
am
Maintaining Clinical Services
• Reappraisal of what we do
• Improved equipment performance
• Better use of less activity
• Lower radiation doses
The
Un
iver
sity
of
No
ttin
gh
am
Establishing Clinical Priority
1. Paediatric studies e.g. oncology and renography 2. Sentinel lymph node localisation 3. Studies in which other imaging modalities are
specifically contraindicated. e.g. patients in renal failure where i.v. contrast
may not be given for CT or MR.
The
Un
iver
sity
of
No
ttin
gh
am
Maintaining Clinical Services Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine” F-18-NaF Reducing waste Avoid wasteful practice e.g. Tc-99m aerosol production Alternative diagnostic modalities CT MRI
The
Un
iver
sity
of
No
ttin
gh
am
Transportation
The
Un
iver
sity
of
No
ttin
gh
am
The silver lining
• The crisis has raised the profile of Nuclear Medicine
• Reappraisal of clinical services.
• Better use of materials and alternative procedures.
• Increased the importance of equipment and software developments.
The
Un
iver
sity
of
No
ttin
gh
am
Reactor production technologies 1. Conventional U-235 fission: Neutron + U-235 --> Mo-99 + neutrons + other fission products 2. Neutron activation of Mo-98: Neutron + Mo-98 --> Mo-99 Accelerator production technologies 1. Linear accelerator photo-fission of U-238 Photon + U-238 --> Mo-99 + neutrons + other fission products 2. Mo-100 transmutation Photon + Mo-100 --> Mo-99 + neutron 3. Direct cyclotron production of Tc-99m: Proton + Mo-100 --> Tc-99m + 2 neutrons
The
Un
iver
sity
of
No
ttin
gh
am
From the early early mornin’ to the early early night,
When I caught miss Molly rockin' at the house of blue lights,
Good Golly Miss Moly